Found: 5
Select item for more details and to access through your institution.
Anti‐CD19 and anti‐BCMA CAR T cell therapy followed by lenalidomide maintenance after autologous stem‐cell transplantation for high‐risk newly diagnosed multiple myeloma.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 5, p. 537, doi. 10.1002/ajh.26486
- By:
- Publication type:
- Article
Sequential CD19 and BCMA‐specific CAR T‐cell treatment elicits sustained remission of relapsed and/or refractory myeloma.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 2, p. 563, doi. 10.1002/cam4.3624
- By:
- Publication type:
- Article
Combination of DNA methylation inhibitor 5-azacytidine and arsenic trioxide has synergistic activity in myeloma.
- Published in:
- European Journal of Haematology, 2009, v. 82, n. 3, p. 176, doi. 10.1111/j.1600-0609.2008.01189.x
- By:
- Publication type:
- Article
Expanded donor natural killer cell and IL-2, IL-15 treatment efficacy in allogeneic hematopoietic stem cell transplantation.
- Published in:
- European Journal of Haematology, 2008, v. 81, n. 3, p. 226, doi. 10.1111/j.1600-0609.2008.01108.x
- By:
- Publication type:
- Article
Mesenchymal Stromal Cells as an Adjuvant Treatment for Severe Late-Onset Hemorrhagic Cystitis after Allogeneic Hematopoietic Stem Cell Transplantation.
- Published in:
- Acta Haematologica, 2014, v. 133, n. 1, p. 72, doi. 10.1159/000362530
- By:
- Publication type:
- Article